scispace - formally typeset
R

Rui-An Wang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  12
Citations -  1156

Rui-An Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Kinase & Estrogen receptor. The author has an hindex of 10, co-authored 12 publications receiving 1111 citations. Previous affiliations of Rui-An Wang include Fourth Military Medical University.

Papers
More filters
Journal ArticleDOI

Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor

TL;DR: Results identify ER-mediated transcription as a nuclear target of MTA1 and indicate that HDAC complexes associated with the MTA1 corepressor may mediate ER transcriptional repression by HRG.
Journal ArticleDOI

Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells.

TL;DR: This study provides evidence to suggest a close correlation between the status of Pak1 kinase activity and base-line invasiveness of human breast cancer cells and breast tumor grades and develops human epithelial MCF-7 clones that overexpressed the kinase-active T423E Pak1 mutant under an inducible tetracycline promoter.
Journal ArticleDOI

P21-Activated Kinase 1 Regulation of Estrogen Receptor-α Activation Involves Serine 305 Activation Linked with Serine 118 Phosphorylation

TL;DR: It is suggested that Pak1 signaling-dependent activation of ER-S305 leads to an enhanced S118 phosphorylation presumably due to a conformational change, and such structural modifications may participate in the development of tamoxifen resistance.
Journal ArticleDOI

PAK1 hyperactivation is sufficient for mammary gland tumor formation.

TL;DR: Results showed that in a transgenic mouse model, overexpression of catalytically active Pak1 leads to the development of malignant mammary tumors and to a variety of other breast lesions, including focal solid nodules, ductal hyperplasia, and mini-intraductal neoplasm and adenoma.